ArticleCancers2024
Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma.
Giovanni Luca Gravina, Alessandro Colapietro, Andrea Mancini, Alessandra Rossetti, Stefano Martellucci, Luca Ventura, Martina Di Franco, Francesco Marampon, Vincenzo Mattei, Leda Assunta Biordi and 2 more
Abstract readPublished Erratum
In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors.
Giovanni Luca GravinaDepartment of Biotechnological and Applied Clinical Sciences, Division of Radiation Oncology, University of L'Aquila, 67100 L'Aquila, Italy.
Alessandro ColapietroDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, 67100 L'Aquila, Italy.
Andrea ManciniDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0009-0005-0327-487X Alessandra RossettiDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, 67100 L'Aquila, Italy.
Stefano MartellucciDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Cellular Pathology, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-3952-3162 Luca VenturaDivision of Pathology, San Salvatore Hospital, 67100 L'Aquila, Italy.
Martina Di FrancoDivision of Pathology, San Salvatore Hospital, 67100 L'Aquila, Italy.
Francesco MaramponDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00100 Rome, Italy.
Vincenzo MatteiBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy.ORCID 0000-0003-4677-088X Leda Assunta BiordiDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Medical Oncology, University of L'Aquila, 67100 L'Aquila, Italy.
Claudio FestucciaDepartment of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-3463-6475 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the original publication [...].
Identifiers
PMID39199697
PMCPMC11352953
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390